| Elizabeth Anne Meier, CCC-SLP | |
|
4665 Tanglevine Dr, Castle Rock, CO 80109-4567 | |
| (303) 387-5825 | |
| Not Available |
| Full Name | Elizabeth Anne Meier |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 4665 Tanglevine Dr, Castle Rock, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093594939 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 219409 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth Anne Meier, CCC-SLP 4665 Tanglevine Dr, Castle Rock, CO 80109-4567 Ph: (303) 387-5825 | Elizabeth Anne Meier, CCC-SLP 4665 Tanglevine Dr, Castle Rock, CO 80109-4567 Ph: (303) 387-5825 |
News Archive
Lightpoint Medical, an innovative medical device company specializing in imaging technologies, announced today that it has received a 2.4M Euro grant from the European Commission as part of the Horizon 2020 European Union Framework Programme for Research and Innovation, enabling the company to carry out a large-scale clinical trial in breast cancer.
PROLOR Biotech, Inc. today reported top-line results from a Phase II four-month treatment extension study of hGH-CTP, its long-acting version of human growth hormone, in growth hormone deficient adults.
In what's believed to be one of the largest population-based studies of Oncotype DX ever conducted, researchers at The University of Texas MD Anderson Cancer Center have found that the commercial diagnostic tool, Oncotype DX, was associated with a decrease in chemotherapy use in younger patients, but not in those over 66 years of age.
The World Health Organization (WHO) has released a report on the latest status of treatment of tuberculosis worldwide. The report shows that around the world more people are getting adequate care for tuberculosis in 2018 than ever before but some vulnerable populations are still left out.
Nektar Therapeutics announced today that data presented at the European Society for Medical Oncology (ESMO) 12th World Congress on Gastrointestinal Cancer demonstrates that NKTR-102, the company's lead oncology compound, exhibits superior activity compared to irinotecan as part of either a monotherapy or combination regimen in tumor models of gastrointestinal cancers.
› Verified 6 days ago
Mrs. Melissa Walker, MSP, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2622 Mclean Ct, Castle Rock, CO 80109 Phone: 720-271-1974 | |
Speech Therapy Co Llc Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 2661 Castle Crest Dr, Castle Rock, CO 80104 Phone: 818-314-4273 | |
Noelle Karen Iorio, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 620 Wilcox St, Castle Rock, CO 80104 Phone: 303-387-0100 | |
Mrs. Jennifer Jackson, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1105 Mcmurdo Cir, Castle Rock, CO 80108 Phone: 720-308-4543 | |
Nicole Belanger, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 701 Prairie Hawk Dr, Castle Rock, CO 80109 Phone: 303-387-0100 | |
Janet Tenbarge, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2661 Mashie Cir, Castle Rock, CO 80109 Phone: 303-246-6489 | |
Caitlin Croasdell, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 620 Wilcox St, Castle Rock, CO 80104 Phone: 303-387-0100 |